The role of CD27-CD70 signaling in myocardial infarction and cardiac remodeling
CD4+ T cells are key players in regulating the inflammatory processes and physiological repair mechanisms engaged after acute myocardial infarction (AMI). Although signaling through the CD27-CD70 co-stimulatory pathway are known to be important in CD4+ T cell activation and proliferation in certain...
Gespeichert in:
| Veröffentlicht in: | International journal of cardiology 2019-03, Vol.278 (C), p.210-216 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 216 |
|---|---|
| container_issue | C |
| container_start_page | 210 |
| container_title | International journal of cardiology |
| container_volume | 278 |
| creator | Li, Wei Zhang, Fengxiao Ju, Chenhui Lv, Suying Huang, Kai |
| description | CD4+ T cells are key players in regulating the inflammatory processes and physiological repair mechanisms engaged after acute myocardial infarction (AMI). Although signaling through the CD27-CD70 co-stimulatory pathway are known to be important in CD4+ T cell activation and proliferation in certain contexts, the role of the CD27-CD70 pathway in AMI remains unclear.
A total of 43 control subjects, 42 unstable angina patients, and 90 AMI patients were enrolled in the present study. The serum levels of soluble CD27 (sCD27) in patients were measured, revealing a significant increase in serum sCD27 levels in AMI patients within 24 h of the cardiac event, after which they decreased. Correlation analyses revealed that serum sCD27 was positively correlated with cardiac troponin I (c-TnI) (r = 0.267, P = 0.011). When anti-CD70 antibody was used to block the CD27-CD70 pathway in MI model mice, we found that this treatment increased left ventricular end-diastolic dimension (LVEDD) (P |
| doi_str_mv | 10.1016/j.ijcard.2018.11.132 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_1692075</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167527318354974</els_id><sourcerecordid>2155157306</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-f940a22b1810ef2c64d46f2622c3505a0526a5a04f3ab098b65ada636e780e6d3</originalsourceid><addsrcrecordid>eNp9kE1LHTEUhkOp1KvtPygldOVmxnxnZiPI9aMFwY1dh9zkjOYyk9hkruC_N8Nol10dcnhO3pcHoe-UtJRQdb5vw97Z7FtGaNdS2lLOPqEN7bRoqJbiM9pUTDeSaX6MTkrZE0JE33df0DEndStZv0H3D0-AcxoBpwFvr5hutlea4BIeox1DfMQh4uk1LUHBjvU12OzmkCK20eN17XCGKXlY-K_oaLBjgW_v8xT9ubl-2P5q7u5vf28v7xonuJyboRfEMrajHSUwMKeEF2pgijHHJZG29lO2DjFwuyN9t1PSequ4At0RUJ6fop_rv6nMwRQXZnBPLsUIbjZU9YxoWaGzFXrO6e8BymymUByMo42QDsUwKiWVmhNVUbGiLqdSMgzmOYfJ5ldDiVl8m71ZfZvFt6HUVN_17Md7wmE3gf939CG4AhcrAFXGS4C8dIXowIe8VPUp_D_hDbE5kDI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2155157306</pqid></control><display><type>article</type><title>The role of CD27-CD70 signaling in myocardial infarction and cardiac remodeling</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Li, Wei ; Zhang, Fengxiao ; Ju, Chenhui ; Lv, Suying ; Huang, Kai</creator><creatorcontrib>Li, Wei ; Zhang, Fengxiao ; Ju, Chenhui ; Lv, Suying ; Huang, Kai</creatorcontrib><description><![CDATA[CD4+ T cells are key players in regulating the inflammatory processes and physiological repair mechanisms engaged after acute myocardial infarction (AMI). Although signaling through the CD27-CD70 co-stimulatory pathway are known to be important in CD4+ T cell activation and proliferation in certain contexts, the role of the CD27-CD70 pathway in AMI remains unclear.
A total of 43 control subjects, 42 unstable angina patients, and 90 AMI patients were enrolled in the present study. The serum levels of soluble CD27 (sCD27) in patients were measured, revealing a significant increase in serum sCD27 levels in AMI patients within 24 h of the cardiac event, after which they decreased. Correlation analyses revealed that serum sCD27 was positively correlated with cardiac troponin I (c-TnI) (r = 0.267, P = 0.011). When anti-CD70 antibody was used to block the CD27-CD70 pathway in MI model mice, we found that this treatment increased left ventricular end-diastolic dimension (LVEDD) (P < 0.01) and left ventricular end-systolic dimension (LVESD) (P < 0.01), and decreased ejection fraction (P < 0.01). Flow cytometric analysis revealed that the percentage of regulatory T cells was lower in blocking antibody-treated mice (P < 0.01), while neutrophils levels were higher (P < 0.01). The number of CD31-positive endothelial cells (P = 0.026) and α-smooth muscle actin-positive arterioles (P < 0.01) were significantly down-regulated in anti-CD70 treated-AMI mice. The formation of the extracellular matrix (ECM) was also impaired.
Serum sCD27 may be a potential biomarker for AMI. Blockade of the CD27-CD70 pathway worsens cardiac dysfunction, aggravates left ventricular remodeling, and impairs scar healing after AMI, resulting in heart failure.
•The circulating sCD27 was increased within 24 h post-MI in patients.•The sCD27 level was correlated with c-TnI.•Blockade of CD27-CD70 pathway enhanced inflammatory response and led to adverse ventricular remodeling.]]></description><identifier>ISSN: 0167-5273</identifier><identifier>EISSN: 1874-1754</identifier><identifier>DOI: 10.1016/j.ijcard.2018.11.132</identifier><identifier>PMID: 30527529</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acute myocardial infarction ; CD27 ; CD70 ; Inflammation ; Ventricular remodeling</subject><ispartof>International journal of cardiology, 2019-03, Vol.278 (C), p.210-216</ispartof><rights>2018 Elsevier B.V.</rights><rights>Copyright © 2018 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-f940a22b1810ef2c64d46f2622c3505a0526a5a04f3ab098b65ada636e780e6d3</citedby><cites>FETCH-LOGICAL-c435t-f940a22b1810ef2c64d46f2622c3505a0526a5a04f3ab098b65ada636e780e6d3</cites><orcidid>0000-0002-5109-4196 ; 0000000251094196</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijcard.2018.11.132$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30527529$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/1692075$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Wei</creatorcontrib><creatorcontrib>Zhang, Fengxiao</creatorcontrib><creatorcontrib>Ju, Chenhui</creatorcontrib><creatorcontrib>Lv, Suying</creatorcontrib><creatorcontrib>Huang, Kai</creatorcontrib><title>The role of CD27-CD70 signaling in myocardial infarction and cardiac remodeling</title><title>International journal of cardiology</title><addtitle>Int J Cardiol</addtitle><description><![CDATA[CD4+ T cells are key players in regulating the inflammatory processes and physiological repair mechanisms engaged after acute myocardial infarction (AMI). Although signaling through the CD27-CD70 co-stimulatory pathway are known to be important in CD4+ T cell activation and proliferation in certain contexts, the role of the CD27-CD70 pathway in AMI remains unclear.
A total of 43 control subjects, 42 unstable angina patients, and 90 AMI patients were enrolled in the present study. The serum levels of soluble CD27 (sCD27) in patients were measured, revealing a significant increase in serum sCD27 levels in AMI patients within 24 h of the cardiac event, after which they decreased. Correlation analyses revealed that serum sCD27 was positively correlated with cardiac troponin I (c-TnI) (r = 0.267, P = 0.011). When anti-CD70 antibody was used to block the CD27-CD70 pathway in MI model mice, we found that this treatment increased left ventricular end-diastolic dimension (LVEDD) (P < 0.01) and left ventricular end-systolic dimension (LVESD) (P < 0.01), and decreased ejection fraction (P < 0.01). Flow cytometric analysis revealed that the percentage of regulatory T cells was lower in blocking antibody-treated mice (P < 0.01), while neutrophils levels were higher (P < 0.01). The number of CD31-positive endothelial cells (P = 0.026) and α-smooth muscle actin-positive arterioles (P < 0.01) were significantly down-regulated in anti-CD70 treated-AMI mice. The formation of the extracellular matrix (ECM) was also impaired.
Serum sCD27 may be a potential biomarker for AMI. Blockade of the CD27-CD70 pathway worsens cardiac dysfunction, aggravates left ventricular remodeling, and impairs scar healing after AMI, resulting in heart failure.
•The circulating sCD27 was increased within 24 h post-MI in patients.•The sCD27 level was correlated with c-TnI.•Blockade of CD27-CD70 pathway enhanced inflammatory response and led to adverse ventricular remodeling.]]></description><subject>Acute myocardial infarction</subject><subject>CD27</subject><subject>CD70</subject><subject>Inflammation</subject><subject>Ventricular remodeling</subject><issn>0167-5273</issn><issn>1874-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LHTEUhkOp1KvtPygldOVmxnxnZiPI9aMFwY1dh9zkjOYyk9hkruC_N8Nol10dcnhO3pcHoe-UtJRQdb5vw97Z7FtGaNdS2lLOPqEN7bRoqJbiM9pUTDeSaX6MTkrZE0JE33df0DEndStZv0H3D0-AcxoBpwFvr5hutlea4BIeox1DfMQh4uk1LUHBjvU12OzmkCK20eN17XCGKXlY-K_oaLBjgW_v8xT9ubl-2P5q7u5vf28v7xonuJyboRfEMrajHSUwMKeEF2pgijHHJZG29lO2DjFwuyN9t1PSequ4At0RUJ6fop_rv6nMwRQXZnBPLsUIbjZU9YxoWaGzFXrO6e8BymymUByMo42QDsUwKiWVmhNVUbGiLqdSMgzmOYfJ5ldDiVl8m71ZfZvFt6HUVN_17Md7wmE3gf939CG4AhcrAFXGS4C8dIXowIe8VPUp_D_hDbE5kDI</recordid><startdate>20190301</startdate><enddate>20190301</enddate><creator>Li, Wei</creator><creator>Zhang, Fengxiao</creator><creator>Ju, Chenhui</creator><creator>Lv, Suying</creator><creator>Huang, Kai</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>OTOTI</scope><orcidid>https://orcid.org/0000-0002-5109-4196</orcidid><orcidid>https://orcid.org/0000000251094196</orcidid></search><sort><creationdate>20190301</creationdate><title>The role of CD27-CD70 signaling in myocardial infarction and cardiac remodeling</title><author>Li, Wei ; Zhang, Fengxiao ; Ju, Chenhui ; Lv, Suying ; Huang, Kai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-f940a22b1810ef2c64d46f2622c3505a0526a5a04f3ab098b65ada636e780e6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acute myocardial infarction</topic><topic>CD27</topic><topic>CD70</topic><topic>Inflammation</topic><topic>Ventricular remodeling</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Wei</creatorcontrib><creatorcontrib>Zhang, Fengxiao</creatorcontrib><creatorcontrib>Ju, Chenhui</creatorcontrib><creatorcontrib>Lv, Suying</creatorcontrib><creatorcontrib>Huang, Kai</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>International journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Wei</au><au>Zhang, Fengxiao</au><au>Ju, Chenhui</au><au>Lv, Suying</au><au>Huang, Kai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of CD27-CD70 signaling in myocardial infarction and cardiac remodeling</atitle><jtitle>International journal of cardiology</jtitle><addtitle>Int J Cardiol</addtitle><date>2019-03-01</date><risdate>2019</risdate><volume>278</volume><issue>C</issue><spage>210</spage><epage>216</epage><pages>210-216</pages><issn>0167-5273</issn><eissn>1874-1754</eissn><abstract><![CDATA[CD4+ T cells are key players in regulating the inflammatory processes and physiological repair mechanisms engaged after acute myocardial infarction (AMI). Although signaling through the CD27-CD70 co-stimulatory pathway are known to be important in CD4+ T cell activation and proliferation in certain contexts, the role of the CD27-CD70 pathway in AMI remains unclear.
A total of 43 control subjects, 42 unstable angina patients, and 90 AMI patients were enrolled in the present study. The serum levels of soluble CD27 (sCD27) in patients were measured, revealing a significant increase in serum sCD27 levels in AMI patients within 24 h of the cardiac event, after which they decreased. Correlation analyses revealed that serum sCD27 was positively correlated with cardiac troponin I (c-TnI) (r = 0.267, P = 0.011). When anti-CD70 antibody was used to block the CD27-CD70 pathway in MI model mice, we found that this treatment increased left ventricular end-diastolic dimension (LVEDD) (P < 0.01) and left ventricular end-systolic dimension (LVESD) (P < 0.01), and decreased ejection fraction (P < 0.01). Flow cytometric analysis revealed that the percentage of regulatory T cells was lower in blocking antibody-treated mice (P < 0.01), while neutrophils levels were higher (P < 0.01). The number of CD31-positive endothelial cells (P = 0.026) and α-smooth muscle actin-positive arterioles (P < 0.01) were significantly down-regulated in anti-CD70 treated-AMI mice. The formation of the extracellular matrix (ECM) was also impaired.
Serum sCD27 may be a potential biomarker for AMI. Blockade of the CD27-CD70 pathway worsens cardiac dysfunction, aggravates left ventricular remodeling, and impairs scar healing after AMI, resulting in heart failure.
•The circulating sCD27 was increased within 24 h post-MI in patients.•The sCD27 level was correlated with c-TnI.•Blockade of CD27-CD70 pathway enhanced inflammatory response and led to adverse ventricular remodeling.]]></abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>30527529</pmid><doi>10.1016/j.ijcard.2018.11.132</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-5109-4196</orcidid><orcidid>https://orcid.org/0000000251094196</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-5273 |
| ispartof | International journal of cardiology, 2019-03, Vol.278 (C), p.210-216 |
| issn | 0167-5273 1874-1754 |
| language | eng |
| recordid | cdi_osti_scitechconnect_1692075 |
| source | Elsevier ScienceDirect Journals Complete |
| subjects | Acute myocardial infarction CD27 CD70 Inflammation Ventricular remodeling |
| title | The role of CD27-CD70 signaling in myocardial infarction and cardiac remodeling |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A53%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20CD27-CD70%20signaling%20in%20myocardial%20infarction%20and%20cardiac%20remodeling&rft.jtitle=International%20journal%20of%20cardiology&rft.au=Li,%20Wei&rft.date=2019-03-01&rft.volume=278&rft.issue=C&rft.spage=210&rft.epage=216&rft.pages=210-216&rft.issn=0167-5273&rft.eissn=1874-1754&rft_id=info:doi/10.1016/j.ijcard.2018.11.132&rft_dat=%3Cproquest_osti_%3E2155157306%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2155157306&rft_id=info:pmid/30527529&rft_els_id=S0167527318354974&rfr_iscdi=true |